"Leishmania" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi.
| Descriptor ID |
D007891
|
| MeSH Number(s) |
B01.268.475.868.488
|
| Concept/Terms |
Leishmania viannia- Leishmania viannia
- Leishmania viannias
- viannias, Leishmania
- Leishmania (Viannia)
- Leishmanias (Viannia)
Leishmania (Leishmania)- Leishmania (Leishmania)
- Leishmanias (Leishmania)
- Leishmania leishmania
- Leishmania leishmanias
- leishmanias, Leishmania
|
Below are MeSH descriptors whose meaning is more general than "Leishmania".
Below are MeSH descriptors whose meaning is more specific than "Leishmania".
This graph shows the total number of publications written about "Leishmania" by people in this website by year, and whether "Leishmania" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
| 2022 | 4 | 0 | 4 |
| 2023 | 4 | 0 | 4 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmania" by people in Profiles.
-
Using machine learning to dissect host kinases required for Leishmania internalization and development. Mol Biochem Parasitol. 2024 12; 260:111651.
-
Aberrant expression of SOCS impairs the anti-leishmanial immune response. Cytokine. 2024 02; 174:156461.
-
Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis. Vaccine. 2023 08 23; 41(37):5400-5411.
-
Genomic analysis of two phlebotomine sand fly vectors of Leishmania from the New and Old World. PLoS Negl Trop Dis. 2023 04; 17(4):e0010862.
-
A short-term method to evaluate anti-leishmania drugs by inhibition of stage differentiation in Leishmania mexicana using flow cytometry. Exp Parasitol. 2023 Jun; 249:108519.
-
How I Approach Leishmaniasis: Diagnosis and Treatment in the United States. J Pediatric Infect Dis Soc. 2022 Dec 05; 11(11):525-532.
-
Bidirectional cytokine-microRNA control: A novel immunoregulatory framework in leishmaniasis. PLoS Pathog. 2022 08; 18(8):e1010696.
-
Leishmania intercepts IFN-?R signaling at multiple levels in macrophages. Cytokine. 2022 09; 157:155956.
-
Atomic structure of the Leishmania spp. Hsp100 N-domain. Proteins. 2022 06; 90(6):1242-1246.
-
Tryp-ing Up Metabolism: Role of Metabolic Adaptations in Kinetoplastid Disease Pathogenesis. Infect Immun. 2021 03 17; 89(4).